KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,058 | -99.8% | 24 | -99.7% | 0.00% | -100.0% |
| Q2 2023 | $1,762,554 | +73.9% | 8,128 | +45.7% | 0.00% | +50.0% |
| Q1 2023 | $1,013,549 | +3898.5% | 5,580 | +4225.6% | 0.00% | – |
| Q4 2022 | $25,348 | -12.6% | 129 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -96.6% | 129 | -98.1% | 0.00% | -100.0% |
| Q2 2022 | $849,000 | +28.8% | 6,724 | +29.1% | 0.00% | +100.0% |
| Q1 2022 | $659,000 | -14.6% | 5,209 | -11.8% | 0.00% | 0.0% |
| Q4 2021 | $772,000 | +2170.6% | 5,907 | +2017.2% | 0.00% | – |
| Q3 2021 | $34,000 | -70.2% | 279 | -72.2% | 0.00% | – |
| Q2 2021 | $114,000 | -5.0% | 1,003 | 0.0% | 0.00% | – |
| Q1 2021 | $120,000 | -82.8% | 1,003 | -85.4% | 0.00% | -100.0% |
| Q4 2020 | $696,000 | +532.7% | 6,855 | +380.0% | 0.00% | – |
| Q3 2020 | $110,000 | -30.8% | 1,428 | 0.0% | 0.00% | – |
| Q2 2020 | $159,000 | – | 1,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |